Howe & Rusling Inc Horizon Therapeutics Public LTD CO Transaction History

Howe & Rusling Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $1,649 - $2,370	28 Added 18.67%	178 $11,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $2,143 - $3,141	-27 Reduced 15.25%	150 $12,000
Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $7,777 - $9,882	90 Added 103.45%	177 $19,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $1,562 - $1,876	17 Added 24.29%	87 $10,000
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $344 - $383	4 Added 6.06%	70 $7,000
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $502 - $668	-7 Reduced 9.59%	66 $6,000
Q4 2020 Feb 08, 2021	SELL	$67.0 - $84.39 $3,149 - $3,966	-47 Reduced 39.17%	73 $5,000
Q3 2020 Nov 06, 2020	BUY	$55.23 - $79.93 $6,627 - $9,591	120 New	120 $9,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.